Redeye provides an update following Iconovo’s Q1 report. We are positive about the report as the results came in better than anticipated; however, we argue the report did not include any major surprises. Furthermore, we look forward to an upcoming outlicensing deal for ICOpre, which we argue could act as a solid near-term trigger for the share and decrease the valuation gap to our base case.
LÄS MER